chr1-186674757-T-C
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_000963.4(PTGS2):c.1411A>G(p.Lys471Glu) variant causes a missense change. The variant allele was found at a frequency of 0.00000811 in 1,603,482 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K471N) has been classified as Uncertain significance.
Frequency
Consequence
NM_000963.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152214Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000166 AC: 4AN: 240858 AF XY: 0.0000154 show subpopulations
GnomAD4 exome AF: 0.00000482 AC: 7AN: 1451268Hom.: 0 Cov.: 31 AF XY: 0.00000416 AC XY: 3AN XY: 721092 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152214Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74364 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1411A>G (p.K471E) alteration is located in exon 10 (coding exon 10) of the PTGS2 gene. This alteration results from a A to G substitution at nucleotide position 1411, causing the lysine (K) at amino acid position 471 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at